Updated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasIndolent Lymphoma
Rituximab key to survival after transplant for mantle cell lymphomaNovember 16, 2017Aggressive Lymphomas
NCI-MATCH: Nivolumab shows promising activity in noncolorectal cancersNovember 15, 2017Aggressive Lymphomas
Event-free survival at 24 months predicts outcomes in peripheral T-cell lymphomasNovember 2, 2017Aggressive Lymphomas
